Accueil • Veille Scientifique • Ceftolozane-tazobactam Versus Meropenem for Treatment of Nosocomial Pneumonia (ASPECT-NP): A Randomised, Controlled, Double-Blind, Phase 3, Non-Inferiority Trial
		Lancet Infect Dis • 2019.09.25
Kollef M.H.,  Nová?ek M.,  Kivistik Ü., et al.
		- Clinical trial
- International
- Ceftolozane-tazobactam, Clinical trial, Drug therapy, Meropenem, Nosocomial Pneumonia